A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

Glaukos Corporation8 sites in 3 countries58 target enrollmentApril 2003

ConditionsOpen-Angle Glaucoma

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Open-Angle Glaucoma
Sponsor: Glaukos Corporation
Enrollment: 58
Locations: 8
Primary Endpoint: Efficacy
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To evaluate the safety and efficacy of a new trabecular bypass that is implanted in conjunction with cataract surgery in open angle glaucoma subjects.

Detailed Description

Glaukos Corporation conducted a clinical research study at multiple investigational sites within Europe (8)

Registry

clinicaltrials.gov

Start Date

April 2003

End Date

December 2009

Last Updated

10 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Glaukos Corporation

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Diagnosed with primary open-angle glaucoma (POAG)
•Subject on at least one glaucoma medication
•Patient requiring cataract surgery and an intraocular lens implantation

Exclusion Criteria

•Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc)
•Angle closure glaucoma